We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
100 result(s) found, displaying 41 to 50
-
Cancellation by sponsorRequested by Gilead Sciences Pty Ltd
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Sofosbuvir/velpatasvir
-
-
Prescription medicine registrationActive ingredients: sacituzumab govitecan.
-
Prescription medicine registrationActive ingredients: sacituzumab govitecan.
-
Prescription medicine registrationActive ingredients: T Cells - Brexucabtagene autoleucel, cryopreserved - T - Tecartus.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Filgotinib maleate
-
Prescription medicine registrationActive ingredients: sofosbuvir; velpatasvir.
-
Cancellation by sponsorRequested by Gilead Sciences Pty Ltd
-
Cancellation by sponsorRequested by Gilead Sciences Pty Ltd